Pharmaceutical executives took a verbal beating, but didn't concede much in a high-profile testimony before the Senate Finance Committee.
Ambitious new bill from GOP Rep. Bruce Westerman aims to tackle costs along with an Obamacare market overhaul.
Washington state will seek an injunction to block the Trump administration's new rule that bars Title X funding from Planned Parenthood.
Here are five issues to watch out for during Tuesday's blockbuster drug prices hearing.
Sen. Chuck Grassley (R-Iowa) signals he will leverage his powerful Senate Finance Committee chairmanship to make sure not-for-profit hospitals are doling out enough charity care.
The CMS approved a request from Colorado to set up a value-based purchasing program for Medicaid, becoming the third state to do so.
Advocates argue that price controls are needed because competition is failing as providers, insurers and manufacturers become larger and larger.
The Affordable Care Act helped Democrats regain control of the House in 2018. But is the status quo enough to stave off progressives' demand for movement to a single-payer program?
The controversial regulation from HHS would bar funding to any clinic that performs abortions and reshape the Title X family planning network.
The Senate Finance Committee is demanding top insulin makers explain why prices for the lifesaving drug are so high.
Republican governors defended their decisions to pursue Medicaid work requirements despite concerns about the loss of coverage.
Louisiana's health department has notified tens of thousands of Medicaid recipients they could be booted from the program after a newly implemented computer check found they earn too much to receive the taxpayer-financed health coverage.